Eskildsen S. F., Coupe P., Fonov V., Manjon J. V., Leung K. K., Guizard N., Wassef S. N., Ostergaard L. R., Collins D. L., Breitner J., Alzheimer's Disease Neuroimaging Initiative (2012). BEaST: brain extraction based on nonlocal segmentation technique, NeuroImage, 59(3), 2362-73. En savoir plus.

Etchamendy N., Konishi K., Pike G.B., Marighetto A., Bohbot V. (2012). Evidence for a virtual human analog of a rodent relational memory task: A study of aging and fMRI in young adults, Hippocampus, 22(4), 869-880. En savoir plus.

Farley S., Dumas S., El Mestikawy S., Giros B. (2012). Increased expression of the Vesicular Glutamate Transporter-1 (VGLUT1) in the prefrontal cortex correlates with differential vulnerability to chronic stress in various mouse strains: effects of fluoxetine and MK-801, Neuropharmacology, 62(1), 503-17. En savoir plus.

Gauthier S. (2012). Management of Alzheimer’s disease using disease-modifying drugs., Neurodegener Dis, 2, 1-4.

Gauthier S., Patterson C., Chertkow H., Gordon M., Herrmann N., Rockwood K., Rosa-Neto P., Soucy J. P. (2012). 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia, Can J Neurol Sci, 39(6 Suppl 5), S1-8. En savoir plus.

Gauthier S., Patterson C., Chertkow H., Gordon M., Herrmann N., Rockwood K., Rosa-Neto P., Soucy J. P. (2012). Recommendations of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4), Can Geriatr J, 15(4), 120-6. En savoir plus.

Gauthier S., Wu L., Rosa-Neto P., Jia J. (2012). Prevention strategies for Alzheimer's disease, Transl Neurodegener, 1(1), 13. En savoir plus.

Hawrylycz M. J., Lein E. S., Guillozet-Bongaarts A. L., Shen E. H., Ng L., Miller J. A., van de Lagemaat L. N., Smith K. A., Ebbert A., Riley Z. L., Abajian C., Beckmann C. F., Bernard A., Bertagnolli D., Boe A. F., Cartagena P. M., Chakravarty M. (2012). An anatomically comprehensive atlas of the adult human brain transcriptome, Nature, 489(7416), 391-9. En savoir plus.

Hong Y., Hay D. L., Quirion R., Poyner D. R. (2012). The pharmacology of adrenomedullin 2/intermedin, British journal of pharmacology, 166(1), 110-20. En savoir plus.

Ihl R., Ferris S., Robert P., Winblad B., Gauthier S., Tennigkeit F. (2012). Detecting treatment effects with combinations of the ADAS-cog items in patients with mild and moderate Alzheimer's disease, Int J Geriatr Psychiatry, 27(1), 15-21. En savoir plus.

Jones A., McMillan M. R., Jones R. W., Kowalik G. T., Steeden J. A., Deanfield J. E., Pruessner J., Taylor A. M., Muthurangu V. (2012). Adiposity is associated with blunted cardiovascular, neuroendocrine and cognitive responses to acute mental stress, PLoS One, 7(6), e39143. En savoir plus.

Kovacevic T., Skelin I., Minuzzi L., Rosa-Neto P., Diksic M. (2012). Reduced metabotropic glutamate receptor 5 in the Flinders Sensitive Line of rats, an animal model of depression: an autoradiographic study, Brain Res Bull, 87(4-5), 406-412. En savoir plus.

Krantic S., Goutagny R., Cavanagh C., Chabot J.G., Colby-Milley J., Williams S., Quirion R. (2012). Nouveaux gènes impliqués dans la mémoire: impact sur la maladie d’Alzhiemer, Annales Académie nationale de médecine, 59-66.

Krantic S., Isorce N., Mechawar N., Davoli M.A., Vignault E., Albuquerque M., Chabot J. G., Moyse E., Chauvin J.P., Aubert I., McLaurin J., Quirion R. (2012). Hippocampal GABAergic neurons are susceptible to amyloid-beta toxicity in vitro and are decreased in number in the Alzheimer's disease TgCRND8 mouse model, J Alzheimers Dis, 29(2), 293-308. En savoir plus.

Kremen W. S., Lachman M. E., Pruessner J., Sliwinski M., Wilson R. S. (2012). Mechanisms of age-related cognitive change and targets for intervention: social interactions and stress, J Gerontol A Biol Sci Med Sci, 67(7), 760-5. En savoir plus.

Lee C. T., Leoutsakos J. M., Lyketsos C. G., Steffens D. C., Breitner J., Norton M. C. (2012). Latent class-derived subgroups of depressive symptoms in a community sample of older adults: the Cache County Study, Int J Geriatr Psychiatry, 27(10), 1061-9. En savoir plus.

Lee W. J., Tsai C. F., Gauthier S., Wang S. J., Fuh J. L. (2012). The association between cognitive impairment and neuropsychiatric symptoms in patients with Parkinson's disease dementia, Int Psychogeriatr, 24(12), 1980-7. En savoir plus.

Leoutsakos J. M., Muthen B. O., Breitner J., Lyketsos C. G. (2012). Effects of non-steroidal anti-inflammatory drug treatments on cognitive decline vary by phase of pre-clinical Alzheimer disease: findings from the randomized controlled Alzheimer's Disease Anti-inflammatory Prevention Trial, Int J Geriatr Psychiatry, 27(4), 364-74. En savoir plus.

Leuzy A., Gauthier S. (2012). Ethical issues in Alzheimer's disease: an overview, Expert Rev Neurother, 12(5), 557-567. En savoir plus.

Liu F., van der Lijn F., Schurmann C., Zhu G., Chakravarty M., Hysi P. G., Wollstein A., Lao O., de Bruijne M., Ikram M. A., van der Lugt A., Rivadeneira F., Uitterlinden A. G., Hofman A., Niessen W. J., Homuth G., de Zubicaray G., McMahon K. L., Thompson P. M., Daboul A., Puls R., Hegenscheid K., Bevan L., Pausova Z., Medland S. E., Montgomery G. W., Wright M. J., Wicking C., Boehringer S., Spector T. D., Paus T., Martin N. G., Biffar R., Kayser M. (2012). A genome-wide association study identifies five loci influencing facial morphology in Europeans, PLoS Genet, 8(9), e1002932. En savoir plus.